Back to Newsroom
Back to Newsroom

True Leaf Grants New Batch of Incentive Stock Options

Monday, 12 December 2016 06:26 PM

True Leaf Medicine International Inc.

Topic:

VANCOUVER, BC / ACCESSWIRE / December 12, 2016 / True Leaf Medicine International Ltd. (CSE: MJ) (FSE: TLA) (the "Company") is pleased to announce that the Company has granted options to purchase an aggregate of 2,799,995 common shares to certain of its directors, officers, employees and consultants at an exercise price of $0.185 per share for a maximum term of five years.

Of this group, five insiders of the Company received a total of 1,642,855 options. All of the options vest immediately.

As a result of this grant, the Company now has a total of 5,879,995 options outstanding, representing 10.2% of its issued and outstanding common shares.

About True Leaf Medicine International Ltd.:

True Leaf Medicine International Ltd., through its wholly-owned subsidiary True Leaf Pet Inc., has entered the $104.9 billion global pet care industry with a line of hemp-focused pet chews and supplements marketed through natural pet health and veterinary channels in Canada, the United States and Europe. The Company has also filed an application under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) to become a Canadian licensed producer through its True Leaf Medicine Inc. subsidiary. It has passed through the preliminary and enhanced screening process of Health Canada's review and is currently awaiting security clearance and "pre-licensing inspection" approval.

For more information, please see the Company's website at www.trueleaf.com.

Contact: Kevin Bottomley, Director
Telephone: +1 778 389 9933
Email: [email protected]
Address: 100 Kalamalka Lake Road, Unit 32, Vernon, British Columbia V1T 9G1 Canada

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS PRESS RELEASE.

FORWARD LOOKING INFORMATION

This press release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks discussed in the Company's continuous disclosure filings available under the Company's profile on www.sedar.com. While the Company may elect to, it does not undertake to update this information at any particular time.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

SOURCE: True Leaf Medicine International Ltd.

Topic:
Back to newsroom
Back to Newsroom
Share by: